Portfolio company
SeQureDX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides off-target gene-editing analysis and safety diagnostics for biotechnology and pharmaceutical firms developing CRISPR-based therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Broken String Biosciences
This company provides a genomics platform to map DNA breaks for cell and gene therapy developers to assess the safety of gene editing.
Mammoth Biosciences
This biotechnology company develops ultracompact CRISPR-based gene editing therapies and diagnostic tools for pharmaceutical partners and healthcare providers.
JUMPCODE Genomics
This company develops CRISPR-based reagent kits that remove unwanted genetic sequences from sequencing libraries for researchers in oncology, infectious disease and basic research.
PathoQuest SAS
This company provides genomic sequencing services for biosafety and quality control testing to biopharmaceutical firms developing vaccines, cell therapies and recombinant drugs.
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
Inscripta
This company provides a digital genome engineering platform for biotechnology, pharmaceutical and agricultural customers to perform automated CRISPR-based gene editing.
Replace Therapeutics
The company develops genome editing technology to insert and delete small DNA sequences for biotechnology firms and healthcare researchers.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
